US EditionElon Musk’s Neuralink raises fresh cash at $9B valuation: Report
- Neuralink, Elon Musk's brain implant company, raised $600 million in May 2025 at a $9 billion pre-money valuation.
- This funding round came after a 2023 valuation of $5 billion established through private stock transactions and was spearheaded by the investment fund associated with Peter Thiel.
- Neuralink is testing a brain implant designed for individuals with spinal cord damage, enabling the first user to operate devices using neural signals.
- The U.S. FDA granted the device a breakthrough designation, and Musk stated the chip could enable "speedy surgical insertions" and treat conditions like depression.
- The new investment suggests growing confidence in Neuralink's technology and potential for broader applications including web browsing and telepathy.
17 Articles
17 Articles
Neuralink, Elon Musk’s brain implant company, raised $600 million in an operation that valued it at $9 billion before the new funding, Semafor reported, citing people with knowledge of the matter. Neuralink did not immediately respond to a request for comment. It was estimated that the startup would be valued at $5 billion in 2023, according to private stock exchanges described to Reuters. The company had previously raised $280 million in a fund…
Elon Musk's Neuralink hits $9 billion valuation after massive fundraise of $600 million: Report
The startup was estimated to be valued at $5 billion in 2023, based on privately executed stock trades described to Reuters. The company had previously raised $280 million in a funding round led by Peter Thiel's Founders Fund.
Elon Musk's Neuralink Hits $9 Billion Valuation With New Funding
Elon Musk’s brain-interface company, Neuralink, has successfully secured $600 million in new funding, elevating its valuation to $9 billion. What Happened: Neuralink’s valuation surged from $3.5 billion in late 2023, according to Pitchbook, to its current $9 billion status, as reported by Semafor. The leap follows the successful implantation of brain chips in three individuals, including a non-verbal man with ALS who recently demonstrated the ch…
Coverage Details
Bias Distribution
- 67% of the sources are Center
To view factuality data please Upgrade to Premium
